MedTrace Logo

Functional Assessment of Ashwagandaha Root Extract During Weight Loss

NCT03112824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-01-30

No results posted yet for this study

Summary

Patients who are involved in a clinical protocol driven 12 week medical weight loss intervention will be randomized to receive either a placebo or 600 mg of an ashwagandha root extract. The study endpoints are primarily the patients self-reported perception of life stress and sleep quality. The working hypothesis of this study is that the addition of aschwagandha to .the medical weight loss program will improve the self-reported perception of life stress and sleep quality

Conditions

  • Stress Reaction
  • Sleep Disturbance
  • Craving
  • Obesity

Interventions

DIETARY_SUPPLEMENT

Ashwagandha Root Extract Capsule

Participants will take one 300 mg capsule of Ashwagandaha Root Extract orally twice a day for 12 weeks.

OTHER

Placebo Capsule

Participants will take one placebo capsule orally twice a day for 12 weeks.

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Warren R Peters, MD MPH · LLU Administrator

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-05
Primary Completion
2021-06-23
Completion
2021-06-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03112824 on ClinicalTrials.gov